Precigen, Inc. (PGEN) Advances Gene & Cell Therapy ResearchPrecigen, Inc.BATS:PGENtraderspro_chartsPrecigen, Inc. (PGEN) is a biotechnology company advancing gene and cell therapies for cancer, autoimmune disorders, and rare diseases. Using its UltraCAR-T® and ActoBiotics® platforms, Precigen develops innovative, precision-based treatments designed to improve safety, efficacy, and patient outcomes. The company’s growth is fueled by promising clinical results, expanding partnerships, and the global push for next-generation therapies that redefine genetic medicine. On the chart, a confirmation bar with rising volume highlights bullish strength. The price has entered the momentum zone after moving above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci line using the Fibonacci snap tool, helping traders lock in gains while leaving room for continued upside potential.